Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy

J Mater Sci Mater Med. 2007 Dec;18(12):2297-302. doi: 10.1007/s10856-007-3130-6. Epub 2007 Jun 12.

Abstract

Amino-functionalized superparamagnetic iron oxide nanoparticles (SPION) were synthesized by coprecipitation method. The particles were characterized by X-ray diffraction (XRD), vibrating sample magnetometer (VSM), scanning electron micrographs (SEM), transmission electron micrographs (TEM) and atomic force micrographs (AFM). The size of the modified particles varied in the range 10-15 nm and did not change significantly after modification. Hepama-1, an excellent humanized monoclonal antibody directed against liver cancer, was conjugated to the SPION to prepare immuno-magnetic nanoparticles (IMN). A direct labeling method was employed to radiolabel IMN with rhenium-188. The radiolabeling efficiency was about 90% with good in vitro stability. (188)Re labeled IMN could markedly kill SMMC-7721 liver cancer cells. Such SPION might be very useful for bio-magnetically targeted radiotherapy in liver cancer treatment.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / pharmacokinetics
  • Cell Proliferation / drug effects
  • Drug Carriers / chemical synthesis*
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods*
  • Ferric Compounds / chemical synthesis*
  • Ferric Compounds / chemistry
  • Ferric Compounds / therapeutic use*
  • Humans
  • Liver Neoplasms / pathology
  • Magnetics*
  • Metal Nanoparticles / chemistry*
  • Metal Nanoparticles / therapeutic use
  • Radioisotopes / pharmacokinetics
  • Rhenium / pharmacokinetics
  • Surface Properties
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Drug Carriers
  • Ferric Compounds
  • Hepama-1 mAb
  • Radioisotopes
  • ferric oxide
  • Rhenium